Cost-related nonadherence to prescription medications in Canada: a scoping review

References

• AllinSLaporteASocioeconomic status and the use of medicines in the Ontario public drug programCan Public Policy2011374563576
   Web of Science ®Google Scholar
• TangKLGhaliWAMannsBJAddressing cost-related barriers to prescription drug use in CanadaCMAJ2013186427628024043654
   PubMed Web of Science ®Google Scholar
• LawMRDawJRChengLMorganSGGrowth in private payments for health care by Canadian householdsHealth Policy20131102–314114623419418
   PubMed Web of Science ®Google Scholar
• Canadian Institute of Health Information (CIHI)Prescribed drug spending in Canada, 2016: a focus on public drug programsOttawa, ONCIHI2016 Available from: https://secure.cihi.ca/estore/product-Family.htm?locale=en&pf=PFC3333Accessed June 10, 2017
   Google Scholar
• MorganSGLawMDawJRAbrahamLMartinDEstimated cost of universal public coverage of prescription drugs in CanadaCMAJ2015187749149725780047
   PubMed Web of Science ®Google Scholar
• SanmartinCHennessyDLuYLawMRTrends in out-of-pocket health care expenditures in Canada, by household income, 1997 to 2009Health Rep20142541317
   PubMed Web of Science ®Google Scholar
• DewaCSHochJSSteeleLPrescription drug benefits and Canada’s uninsuredInt J Law Psychiatry200528549651316125777
   PubMed Web of Science ®Google Scholar
• MorganSGDawJRLawMRRethinking Pharmacare in CanadaCommentary 384Toronto, ONC.D. Howe Institute2013 Available from: https://www.cdhowe.org/sites/default/files/attachments/research_papers/mixed/Commentary_384_0.pdfAccessed May 27, 2017
   Google Scholar
• MorganSGBootheKUniversal prescription drug coverage in Canada: Long-promised yet undeliveredHealthcare Management Forum201629624725427744279
   PubMedGoogle Scholar
• DemersVMeloMJackeviciusCComparison of provincial prescription drug plans and the impact on patients’ annual drug expendituresCMAJ2008178440540918268266
   PubMed Web of Science ®Google Scholar
• PietteJDHeislerMWagnerTHCost-Related Medication Under-use Among Chronically III Adults: the Treatments People Forgo, How Often, and Who Is at RiskAmerican Journal of Public Health2004941782178715451750
   PubMed Web of Science ®Google Scholar
• PietteJDHeislerMHorneRCaleb AlexanderGA conceptually based approach to understanding chronically ill patients’ responses to medication cost pressuresSoc Sci Med200662484685716095789
   PubMed Web of Science ®Google Scholar
• SoumeraiSBBenefits and risks of increasing restrictions on access to costly drugs in MedicaidHealth Aff (Millwood)200423113514615002636
   PubMed Web of Science ®Google Scholar
• PietteJDCost-related medication underuse: a window into patients’ medication-related concernsDiabetes Spectr20092227780
   Google Scholar
• PietteJDBeardARoslandAMMcHorneyCABeliefs that influence cost-related medication non-adherence among the “haves” and “have nots” with chronic diseasesPatient Prefer Adherence2011538939621949602
   PubMed Web of Science ®Google Scholar
• WagnerTHHeislerMPietteJDPrescription drug co-payments and cost-related medication underuseHealth Econ Policy Law20083Pt 1516718634632
   PubMed Web of Science ®Google Scholar
• Cost-Related Medication Underuse: A Window Into Patients’ Medication- Related ConcernsDiabetes Spectrum2009227780
   Google Scholar
• ZhangJXLeeJUMeltzerDORisk factors for cost-related medication non-adherence among older patients with diabetesWorld J Diabetes20145694595025512801
   PubMedGoogle Scholar
• BlomqvistABusbyCFeasible Pharmacare in the Federation: A Proposal to Break the GridlockC.D. Howe Institute ebrief 21710 21, 2015
   Google Scholar
• PicardAPharmacare talk, but still no actionThe Globe and Mail4 19, 2018 Section A:5
   Google Scholar
• ArmstrongRHallBJDoyleJWatersE“Scoping the scope” of a cochrane reviewJ Public Health (Bangkok)2011331147150
   PubMed Web of Science ®Google Scholar
• ArkseyHO’MalleyLScoping studies: towards a methodological frameworkInt J Soc Res Methodol2005811932
   Google Scholar
• TriccoACLillieEZarinWA scoping review on the conduct and reporting of scoping reviewsBMC Med Res Methodol2016161526857112
   PubMed Web of Science ®Google Scholar
• ColquhounHLLevacDO’BrienKKScoping reviews: time for clarity in definition, methods, and reportingJ Clin Epidemiol201467121291129425034198
   PubMed Web of Science ®Google Scholar
• LawMRChengLDhallaIAHeardDMorganSGThe effect of cost on adherence to prescription medications in CanadaCMAJ2012184329730222249979
   PubMed Web of Science ®Google Scholar
• HennessyDSanmartinCRonksleyPOut-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic diseaseHealth Rep201627638
   PubMed Web of Science ®Google Scholar
• KennedyJMorganSCost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven CountriesClin Ther200931121321919243719
   PubMed Web of Science ®Google Scholar
• UngarWJKozyrskyjAPatersonMAhmadFEffect of cost-sharing on use of asthma medication in childrenArch Pediatr Adolesc Med2008162210411018250232
   PubMedGoogle Scholar
• TamblynREgualeTHuangAWinsladeNDoranPThe incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort studyAnn Intern Med2014160744145024687067
   PubMed Web of Science ®Google Scholar
• KempARougheadEPreenDGloverJSemmensJDeterminants of self-reported medicine underuse due to cost: a comparison of seven countriesJ Health Serv Res Policy201015210611420203082
   PubMed Web of Science ®Google Scholar
• LeeAMorganSCost-related nonadherence to prescribed medicines among older Canadians in 2014: a cross-sectional analysis of a telephone surveyCMAJ Open201751E40E44
   Google Scholar
• KennedyJMorganSA cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of HealthClin Ther20062881217122416982299
   PubMed Web of Science ®Google Scholar
• RotermannMSanmartinCHennessyDArthurMPrescription medication use by Canadians aged 6 to 79Health Rep201425639
   Web of Science ®Google Scholar
• DesprésFPerreaultSLalondeLForgetAKettaniFZBlaisLImpact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance programCan J Cardiol201430556056724613090
   PubMed Web of Science ®Google Scholar
• CampbellDJKing-ShierKHemmelgarnBRSelf-reported financial barriers to care among patients with cardiovascular-related chronic conditionsHealth Rep2014255312
   Web of Science ®Google Scholar
• HunterCEPalepuAFarrellSGogosisEO’BrienKHwangSWBarriers to prescription medication adherence among homeless and vulnerably housed adults in three Canadian citiesJ Prim Care Community Health20156315416125428404
   PubMedGoogle Scholar
• DesprésFForgetAKettaniFZBlaisLImpact of patient reimbursement timing and patient out-of-pocket expenses on medication adherence in patients covered by private drug insurance plansJ Manag Care Spec Pharm201622553954727123915
   PubMed Web of Science ®Google Scholar
• ThanassoulisGKarpIHumphriesKTuJVEisenbergMJPiloteLImpact of restrictive prescription plans on heart failure medication useCirc Cardiovasc Qual Outcomes20092548449020031881
   PubMed Web of Science ®Google Scholar
• YaoSLixLShevchukYTeareGBlackburnDFReduced out-of-pocket costs and medication adherence – a population based studyJ Popul Ther Clin Pharmacol2018251e1e729949684
   PubMed Web of Science ®Google Scholar
• AssayagJForgetAKettaniFZBeauchesneMFMoisanJBlaisLThe impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort studyCan J Psychiatry201358423323923547647
   PubMed Web of Science ®Google Scholar
• AnisAHGuhDPLacailleDWhen patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptionsCMAJ2005173111335134016301701
   PubMed Web of Science ®Google Scholar
• DawJRMorganSGStitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010Health Policy20121041192621978939
   PubMed Web of Science ®Google Scholar
• GuilcherSMunceSConklinJThe financial burden of prescription drugs for neurological conditions in Canada: results from the National Population Health Study of Neurological ConditionsHealth Policy2017121438939628215356
   PubMed Web of Science ®Google Scholar
• GoldsmithLJKolhatkarAPopowichDHolbrookAMMorganSGLawMRUnderstanding the patient experience of cost-related non-adherence to prescription medications through typology development and applicationSoc Sci Med2017194515929065312
   PubMed Web of Science ®Google Scholar
• DhaliwalKKKing-ShierKMannsBJHemmelgarnBRStoneJACampbellDJExploring the impact of financial barriers on secondary prevention of heart diseaseBMC Cardiovasc Disord20171716128196528
   PubMed Web of Science ®Google Scholar
• WangCLiQSweetmanAHurleyJMandatory universal drug plan, access to health care and health: evidence from CanadaJ Health Econ201544809626410422
   PubMed Web of Science ®Google Scholar
• TamblynRLapriseRHanleyJAAdverse events associated with prescription drug cost-sharing among poor and elderly personsJAMA2001285442142911242426
   PubMed Web of Science ®Google Scholar
• LexchinJGrootendorstPEffects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidenceInt J Health Serv200434110112215088676
   PubMed Web of Science ®Google Scholar
• ZhengBPouloseAFulfordMHolbrookAA pilot study on cost-related medication nonadherence in OntarioJ Popul Ther Clin Pharmacol2012192e239e24722805096
   PubMedGoogle Scholar
• MillarWJDisparities in prescription drug insurance coverageHealth Rep19991041131 (ENG); 9-30(FRE).10607410
   PubMedGoogle Scholar
• KratzerJChengLAllinSLawMRThe impact of private insurance coverage on prescription drug use in Ontario, CanadaHealthc Policy2015104627426142359
   PubMedGoogle Scholar
• HanleyGEPrescription drug insurance and unmet need for health care: a cross-sectional analysisOpen Med200933e178e18321603050
   PubMedGoogle Scholar
• ZhongHEquity in pharmaceutical utilization in Ontario: a cross-section and over time analysisCan Public Policy2007334487507
   Web of Science ®Google Scholar
• AllinSHurleyJInequity in publicly funded physician care: what is the role of private prescription drug insurance?Health Econ200918101218123219097042
   PubMed Web of Science ®Google Scholar
• LawMRChengLKolhatkarAThe consequences of patient charges for prescription drugs in Canada: a cross-sectional surveyCMAJ Open201861E63E70
   Google Scholar
• KapurVBasuKDrug coverage in Canada: who is at risk?Health Policy200571218119315607380
   PubMed Web of Science ®Google Scholar
• LuffmanJOut-of-pocket spending on prescription drugsPerspect Lab Income200569513
   Google Scholar
• McLeodLBerezaBGShimMGrootendorstPFinancial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey dataOpen Med201151e1e922046212
   PubMedGoogle Scholar
• Simon-TuvalTTrikiNChodickGGreenbergDDeterminants of cost-related nonadherence to medications among chronically ill patients in maccabi healthcare services, IsraelValue Health Reg Issues201441414629702805
   PubMedGoogle Scholar
• RahimiARSpertusJAReidKJBernheimSMKrumholzHMFinancial barriers to health care and outcomes after acute myocardial infarctionJAMA2007297101063107217356027
   PubMed Web of Science ®Google Scholar
• SokolMCMcGuiganKAVerbruggeRREpsteinRSImpact of medication adherence on hospitalization risk and healthcare costMed Care200543652153015908846
   PubMed Web of Science ®Google Scholar
• PietteJDWagnerTHPotterMBSchillingerDHealth insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of careMed Care200442210210914734946
   PubMed Web of Science ®Google Scholar
• AtellaVSchafheutleENoycePHassellKAffordability of medicines and patients’ cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UKAppl Health Econ Health Policy200541233516076236
   PubMedGoogle Scholar
• MusichSChengYWangSSHommerCEHawkinsKYehCSPharmaceutical cost-saving strategies and their association with medication adherence in a medicare supplement populationJ Gen Intern Med20153081208121425666213
   PubMed Web of Science ®Google Scholar
• KennedyJUsing cost-related medication nonadherence to assess social and health policiesAm J Public Health2018108216817029320301
   PubMed Web of Science ®Google Scholar
• NaciHSoumeraiSBRoss-DegnanDPersistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006–2011Med Care2014521195195625122530
   PubMed Web of Science ®Google Scholar
• KennedyJErbCPrescription noncompliance due to cost among adults with disabilities in the United StatesAm J Public Health20029271120112412084695
   PubMed Web of Science ®Google Scholar
• JongbloedLDisability policy in Canada. An overviewJ Disabil Policy Stud2003134203209
   Google Scholar